Literature DB >> 1596924

Glucuronoxylomannan of Cryptococcus neoformans serotype D: structural analysis by gas-liquid chromatography-mass spectrometry and by 13C-nuclear magnetic resonance spectroscopy.

R Cherniak1, L C Morris, S H Turner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1596924     DOI： 10.1016/0008-6215(92)80023-t

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN： 0008-6215            Impact factor:   2.104


× No keyword cloud information.
  3 in total

1.  In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.

Authors:  W Cleare; R Cherniak; A Casadevall
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

2.  Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan.

Authors:  J K van de Wetering; F E J Coenjaerts; A B Vaandrager; L M G van Golde; J J Batenburg
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 3.  Polysaccharide antigens of the capsule of Cryptococcus neoformans.

Authors:  R Cherniak; J B Sundstrom
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.